MoneyWorks4Me

Wockhardt board to consider unaudited financial result

29 Jan 2014 Evaluate

Wockhardt has informed that a meeting of the Board of Directors of the Company will be held on February 09, 2014, inter alia, to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2013 (Q3). Consideration of Interim Dividend.

The above information is a part of company’s filings submitted to BSE

 

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..